UPEXI, INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by UPEXI, INC. on June 24, 2026. The Company is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol "UPXI". The filing addresses a regulatory compliance notice from Nasdaq and a corporate governance event regarding index inclusion.
Key Financial Metrics
This filing does not contain standard financial performance data such as revenue, profit, cash flow, or liquidity metrics. However, it discloses the following material financial instruments and transaction values:
- Convertible Note Issuance 1: Secured convertible notes with an aggregate original principal amount of $151,169,169 issued on July 9, 2025, in exchange for Solana (SOL). Conversion price: $4.25 per share.
- Convertible Note Issuance 2: Secured convertible promissory note with an original principal amount of approximately $36 million issued on January 9, 2026, in exchange for 265,500 locked SOL. Conversion price: $2.39 per share.
- Total Dilution Risk: The Staff determined these notes are convertible into 20% or more of the Company's pre-transaction shares and voting power.
Material Changes and Regulatory Status
The primary material change reported is a determination by the Nasdaq Listing Qualifications staff that the Company is not in compliance with Nasdaq Listing Rule 5635(a). The violation stems from the issuance of the convertible notes described above without obtaining prior shareholder approval, as the aggregate issuance exceeded 20% of pre-transaction shares.
- Current Status: The notice has no immediate effect on the listing or trading of the Company's common stock.
- Compliance Deadline: The Company has 45 calendar days (until August 10, 2026) to submit a plan to regain compliance.
- Extension Possibility: If a plan is accepted, Nasdaq may grant an extension of up to 180 calendar days to evidence compliance.
Outlook, Risks, and Other Events
Management Commentary and Risks: The Company is reviewing options to regain compliance and intends to submit a plan within the required timeframe. Management explicitly states there can be no assurance that the plan will be accepted or that the Company will successfully regain compliance with Nasdaq Listing Rules. Failure to comply could result in delisting.
Other Events: On June 26, 2026, the Company announced its addition to the Russell Microcap Index, effective June 29, 2026.
Investor Verification Checklist
- Verify the specific terms and conversion mechanics of the $151.2 million and $36 million convertible notes issued in 2025 and 2026.
- Monitor the Company's submission of a compliance plan to Nasdaq by the August 10, 2026 deadline.
- Assess the risk of potential delisting if the compliance plan is rejected or if the Company fails to regain compliance within the extended period.
- Confirm the impact of the Russell Microcap Index inclusion on trading volume and institutional ownership.